FDA — authorised 3 May 1995
- Marketing authorisation holder: ROCHE PALO
- Status: approved
FDA authorised Cellcept on 3 May 1995
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 3 May 1995.
ROCHE PALO holds the US marketing authorisation.